Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile

Substantial proportion of Crohn's disease (CD) patients shows no response or a limited response to treatment with infliximab (IFX) and to identify biomarkers of response would be of great clinical and economic benefit. The expression profile of five genes (S100A8-S100A9, G0S2, TNFAIP6, and IL11...

Descripción completa

Detalles Bibliográficos
Autores principales: Medrano, Luz María, Taxonera, Carlos, González-Artacho, Cristina, Pascual, Virginia, Gómez-García, María, Barreiro-de Acosta, Manuel, Pérez-Calle, José L., Bermejo, Fernando, López-Sanromán, Antonio, Martín Arranz, Dolores, Gisbert, Javier P., Mendoza, Juan Luis, Martín, Javier, Núñez, Concepción, Urcelay, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539178/
https://www.ncbi.nlm.nih.gov/pubmed/26339133
http://dx.doi.org/10.1155/2015/318207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539178/
https://www.ncbi.nlm.nih.gov/pubmed/26339133
http://dx.doi.org/10.1155/2015/318207

Ejemplares similares